Addition of February 27, 2021 effective date for codes 0031A and 91303. Guidelines and parenthetical notes are only effective for codes that have received FDA Emergency Use Authorization (EUA) approval.
Removal of FDA approval pending symbol (-) from code 91303.
Addition of revised Evaluation and Management guideline that include vaccine codes 0001A, 0002A, 0011A, 0012A, 0021A,
0022A, 0031A, 91300, 91301, 91302, 91303.
Update vaccine code range from 90476-90749 to 90476-90756 throughout the code set.
90626 Tick-borne encephalitis virus vaccine, inactivated; 0.25 mL dosage, for intramuscular use
90627 Tick-borne encephalitis virus vaccine, inactivated; 0.5 mL dosage, for intramuscular use
90671 Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use
90677 Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use
90758 Zaire ebolavirus vaccine, live, for intramuscular use
Download AMA PDF
Source: https://www.ama-assn.org/system/files/2021-01/vaccine-long-descriptors.pdf